BF Biosciences Limited - BFBIO

Rs 212.78

Change -5.22

On Feb 14

Trades end of day

Last trade on Feb 14, 2025 Day's range Rs 210.00 - 219.00
Change Rs -5.22 52 week range Rs 74.55 - 253.97
Open Rs 218.00 Volume 1,486,264
Close Rs 212.78 Previous Close Rs 212.78

BFBIO Company Meetings

No Meetings
 

BFBIO Trade Activity

Period High Low Volume
1M 229.23 203.10 35,331,555.00; Avg 1,766,577.75
3M 243.36 124.30 152,437,815.00; Avg 2,419,647.86
6M 243.36 76.55 193,199,165.00; Avg 1,521,253.27
1Y 243.36 76.55 193,199,165.00; Avg 788,568.02
 
 

Latest Annual Financials

Financial Year O/S Shares 0.00m
Net Profit Rs 0.00m Market Cap Rs 0.00m
EPS 0.00 P/E 0.00
Par Value Rs 0.00 Book Value 0.00
Net Worth Rs 0.00m Outstanding Shares 0.00m
Dividend Rs 0.00 ROE 0.00%
Dividend Yield 0.00% Divident Payout 0.00%
Earnings Yield 0.00% Sharia No
 

Price Chart

Yasir Mahmood Securities has partnered with TradingView for its charting solution.
A comprehensive trading platform which offers intuitive analytical tools, stock screener and real time economic calendar data to track key financial events.

 

The company is in the Pharmaceuticals sector.

 

Other Companies in This Sector

Company Current Change Date
Abbot Laboratories Rs 1,230.23 -0.47% Feb 14, 2025
AGP Limited Rs 166.72 -1.46% Feb 14, 2025
BF Biosciences Limited Rs 212.78 -2.39% Feb 14, 2025
Citi Pharma Limited Rs 101.91 -2.83% Feb 14, 2025
Ferozsons Laboratories Limited Rs 352.45 -2.64% Feb 14, 2025
Glaxosmithkline Rs 390.40 -2.64% Feb 14, 2025
Glaxo Healthcare Pakistan Rs 120.23 -3.20% Jan 30, 2023
Haleon Pakistan Limited Rs 796.92 -2.08% Feb 14, 2025
Highnoon Laboratories Rs 857.16 -0.91% Feb 14, 2025
Hoechst Pakistan Limited Rs 2,839.77 0.00% Feb 14, 2025
IBL Healthcare Limited Rs 39.57 -0.10% Feb 14, 2025
IBL Healthcare Limited (r) Rs 0.00 0.00% Feb 16, 2025
Liven Pharma Limited Rs 136.02 -4.81% Feb 14, 2025
Macter International Limited Rs 269.80 1.22% Feb 14, 2025
Macter International Limited (r) Rs 0.00 0.00% Feb 16, 2025
 

Shareholding Pattern

Year Individual Institutions Investment Companies Foreign Investors Government Shareholders Other